AMC makes bold call that sends its stock crashing
AMC Entertainment Holdings, Inc (AMC) has spent 2026 trying to convince Wall Street that the worst is behind it.
Box office has been recovering, attendance is climbing, and the business is finally gaining momentum.
Then management made a move that erased a quarter of the stock’s value in a single session.
On June 23, AMC set the terms of a $200 million stock offering, its second major capital raise in less than two weeks, and investors did not take it as a sign of strength.
Shares of the company tumbled roughly 25% on the news, dragging the stock back toward its early-2026 lows.
For investors, the sell-off was driven by fear of shareholder dilution.
Why AMC’s $200 million stock sale rattled investors
AMC agreed to sell 95.25 million new shares to institutional investors, the company announced.
It priced the shares at $2.10 each, a steep 24% discount to the prior close, according to Stocktwits.
More Entertainment Stocks:
- AMC stock traders ignoring warning signs send shares surging
- Disney faces a box office test with ‘Toy Story 5’
- New fast-food meme stock surges 25% as retail traders pile in
That discount sits at the heart of the problem.
Shares sold below market price pull the whole stock toward that level, and every existing share now represents a smaller slice of the company.
The market reacted fast.
AMC fell as much as 27% intraday, TipRanks reported, its sharpest drop in months.
AMC’s debt cleanup comes at a real cost to shareholders
Here’s the logic behind AMC’s capital raise:
The company plans to use most of the proceeds to redeem all $125.5 million of its 6.125% senior subordinated notes due 2027, according to its SEC filing.
Fully repaying that debt lowers interest costs and clears out a repayment deadline that is set to arrive soon.
Roth Capital Partners served as the sole placement agent. The offering closed on June 25, and AMC expects net proceeds of about $189 million after fees.
The trouble investors have with this move is timing.
AMC had just completed a $150 million at-the-market offering on June 11, selling roughly 105.3 million shares. Two raises in twelve days make traders worried that equity issuance is becoming a routine funding tool.
AMC’s box office recovery is real, but mostly priced in
It is worth noting that even though the stock is down, the underlying business is improving.
AMC welcomed 25.5 million guests in May, its busiest May since 2019, and first-quarter revenue climbed to $1.05 billion from $862.5 million a year earlier.
A record-breaking Toy Story 5 opening drew more than 4.8 million moviegoers to its screens.
Related: Netflix faces fresh trouble from new lawsuit
Wall Street noticed the growth.
B. Riley analyst Drew Crum lifted his price target to $2.25 from $2, Intellectia reported. However, he warns that much of the box office optimism is already baked into the stock’s price.
CEO Adam Aron also bought 250,000 shares himself this month, a Form 4 filing shows.
Three things still weighing on AMC stock
Before AMC’s business recovery can push the stock price higher, the shareholder dilution has to stop.
Here is what still hangs over the company’s shares:
- Heavy share issuance. Two capital raises in two weeks added roughly 200 million shares to an already large pool.
- A deep debt load. AMC still carries close to $7.9 billion in total debt even after redeeming the 2027 notes.
- Cautious analysts. The consensus rating sits at hold, with an average target near $1.96, below where shares traded for much of June.
What AMC investors should watch next
The stock now trades around $1.89, near the low end of its 52-week range of $0.93 to $3.60, Yahoo Finance data shows.
For the shares to climb from here, AMC needs the summer box office to deliver and management to slow the pace of equity raises. A strong second-half slate could compress the debt-reduction timeline that has weighed on the stock for years.
The risk is clear. If AMC keeps funding itself by selling stock, even a genuine box office rebound may struggle to lift the value of each share.
For now, the dilution concern is the biggest catalyst.
Related: Paramount makes bold legal move for Warner Bros. deal
